Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan D Richman

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cancer Research Communications|July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional SignaturesUmair Mahmood, Andrew Blake, Sanjay Rathee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR TrialChristopher J M Williams, Richard Gray, Robert K Hills, et al.
Gastroenterology|June 21, 2020
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep LearningAmelie Echle, Heike Irmgard Grabsch, Philip Quirke, et al.
Gut|July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learningKorsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
British Journal of Cancer|July 23, 2025
The colorectal liver metastasis growth pattern phenotype is not dependent on genotypeDiederik J Höppener, Sanne M L Verheul, Pieter M H Nierop, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2021
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in <i>RAS</i> Wild-Type Metastatic Colorectal CancerChristopher J M Williams, Jenny F Seligmann, Faye Elliott, et al.
British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Oncotarget|October 4, 2017
<i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancerLinda J W Bosch, Geert Trooskens, Petur Snaebjornsson, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer Research Communications|July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional SignaturesUmair Mahmood, Andrew Blake, Sanjay Rathee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR TrialChristopher J M Williams, Richard Gray, Robert K Hills, et al.
Gastroenterology|June 21, 2020
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep LearningAmelie Echle, Heike Irmgard Grabsch, Philip Quirke, et al.
Gut|July 22, 2020
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learningKorsuk Sirinukunwattana, Enric Domingo, Susan D Richman, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
British Journal of Cancer|July 23, 2025
The colorectal liver metastasis growth pattern phenotype is not dependent on genotypeDiederik J Höppener, Sanne M L Verheul, Pieter M H Nierop, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2021
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in <i>RAS</i> Wild-Type Metastatic Colorectal CancerChristopher J M Williams, Jenny F Seligmann, Faye Elliott, et al.
British Journal of Cancer|July 21, 2020
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G Craig, Matthew P Humphries, Matthew Alderdice, et al.
Oncotarget|October 4, 2017
<i>Decoy receptor 1</i> (<i>DCR1)</i> promoter hypermethylation and response to irinotecan in metastatic colorectal cancerLinda J W Bosch, Geert Trooskens, Petur Snaebjornsson, et al.
Pageof 5